Join
Live feed
·
PRReleasevia Quantisnow
Lantern Pharma Inc. logo

Lantern Pharma and Starlight Therapeutics Announce FDA Clearance of IND for a Planned Phase 1 Pediatric CNS Cancer Trial of STAR-001

ByQuantisnow·Wall Street's wire, on your screen.
LTRN· Lantern Pharma Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track LTRN (Lantern Pharma Inc.) and more on Quantisnow.